Telmisartan Attenuates Experimental Liver Fibrosis Through Suppression Of Hepatic Stellate Cell Activation And Tgf-Β/Smad Signaling. (2026). The Review of Diabetic Studies , 62-76. https://doi.org/10.70082/y1zx3j95